Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

NCT05675787 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Atypical Endometrial Hyperplasia
Endometrial Carcinoma Stage I

Interventions

DRUG: Medroxyprogesterone acetate + Atorvastatin

Sponsor

Peking University People's Hospital